Barclays PLC Inogen Inc Transaction History
Barclays PLC
- $357 Billion
- Q4 2024
A detailed history of Barclays PLC transactions in Inogen Inc stock. As of the latest transaction made, Barclays PLC holds 65,826 shares of INGN stock, worth $535,165. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65,826
Previous 55,508
18.59%
Holding current value
$535,165
Previous $539,000
12.06%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding INGN
# of Institutions
146Shares Held
20.9MCall Options Held
88.5KPut Options Held
116K-
Camber Capital Management LP Boston, MA2MShares$16.3 Million0.42% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$13.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.46MShares$11.9 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.36MShares$11 Million0.3% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN849KShares$6.9 Million0.0% of portfolio
About Inogen Inc
- Ticker INGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 22,866,500
- Market Cap $186M
- Description
- Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...